RxSight (RXST) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $4.67, +3.32% vs the prior close of $4.52.
- Volume 609.20K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RXST jumps 3.3% to $4.67. Closed at $4.67, +3.32% vs the prior close of $4.52. Day range $4.55–$4.71, opened at $4.59.
RXST daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — RXST jumps 3.3% to $4.67
- Closed at $4.67, +3.32% vs the prior close of $4.52. Day range $4.55–$4.71, opened at $4.59.
- Volume was 609.20K shares, 0.7x its 50-day average of 820.12K.
- Price is -18.9% vs its 50-day average ($5.76) and -29.7% vs its 200-day average ($6.65).
- 52-week range $4.40–$13.22; today's close sits at 3% of that range, 64.7% below the 52-week high.
Oct 14, 2026 — RXST ends flat (-0.2%) to $4.52, a 52-week low, 4 down days in a row
- Closed at $4.52, -0.22% vs the prior close of $4.53. Day range $4.40–$4.55, opened at $4.46.
- Volume was 826.70K shares, 1.0x its 50-day average of 816.50K.
- Price is -22.0% vs its 50-day average ($5.79) and -32.3% vs its 200-day average ($6.68).
- 52-week range $4.40–$13.22; today's close sits at 1% of that range, 65.8% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — RXST dips 2.8% to $4.53, a 52-week low, 3 down days in a row
- Closed at $4.53, -2.79% vs the prior close of $4.66. Day range $4.45–$4.77, opened at $4.68.
- Volume was 694.90K shares, 0.8x its 50-day average of 827.26K.
- Price is -22.2% vs its 50-day average ($5.83) and -32.5% vs its 200-day average ($6.71).
- 52-week range $4.45–$13.22; today's close sits at 1% of that range, 65.7% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — RXST slides 3.1% to $4.66
- Closed at $4.66, -3.12% vs the prior close of $4.81. Day range $4.55–$4.98, opened at $4.85.
- Volume was 834.60K shares, 1.0x its 50-day average of 821.39K.
- Price is -20.5% vs its 50-day average ($5.86) and -30.9% vs its 200-day average ($6.74).
- 52-week range $4.48–$13.22; today's close sits at 2% of that range, 64.8% below the 52-week high.
Oct 9, 2026 — RXST dips 0.8% to $4.81
- Closed at $4.81, -0.82% vs the prior close of $4.85. Day range $4.75–$4.94, opened at $4.83.
- Volume was 521.90K shares, 0.6x its 50-day average of 821.15K.
- Price is -18.3% vs its 50-day average ($5.89) and -29.0% vs its 200-day average ($6.77).
- 52-week range $4.48–$13.22; today's close sits at 4% of that range, 63.6% below the 52-week high.
Oct 8, 2026 — RXST rises 1.0% to $4.85
- Closed at $4.85, +1.04% vs the prior close of $4.80. Day range $4.68–$4.86, opened at $4.74.
- Volume was 938.30K shares, 1.1x its 50-day average of 821.08K.
- Price is -18.0% vs its 50-day average ($5.91) and -28.8% vs its 200-day average ($6.81).
- 52-week range $4.48–$13.22; today's close sits at 4% of that range, 63.3% below the 52-week high.
Oct 7, 2026 — RXST jumps 3.2% to $4.80
- Closed at $4.80, +3.23% vs the prior close of $4.65. Day range $4.61–$4.95, opened at $4.61.
- Volume was 842.20K shares, 1.0x its 50-day average of 830.85K.
- Price is -19.2% vs its 50-day average ($5.94) and -29.9% vs its 200-day average ($6.85).
- 52-week range $4.48–$13.22; today's close sits at 4% of that range, 63.7% below the 52-week high.
Oct 6, 2026 — RXST dips 2.3% to $4.65, a 3-month low
- Closed at $4.65, -2.31% vs the prior close of $4.76. Day range $4.60–$4.76, opened at $4.76.
- Volume was 623.00K shares, 0.7x its 50-day average of 838.07K.
- Price is -22.0% vs its 50-day average ($5.96) and -32.5% vs its 200-day average ($6.89).
- 52-week range $4.48–$13.22; today's close sits at 2% of that range, 64.8% below the 52-week high.
Oct 5, 2026 — RXST rises 1.7% to $4.76
- Closed at $4.76, +1.71% vs the prior close of $4.68. Day range $4.62–$4.80, opened at $4.70.
- Volume was 483.80K shares, 0.6x its 50-day average of 845.26K — lighter than usual.
- Price is -20.5% vs its 50-day average ($5.98) and -31.3% vs its 200-day average ($6.93).
- 52-week range $4.48–$13.22; today's close sits at 3% of that range, 64.0% below the 52-week high.
Oct 2, 2026 — RXST dips 1.5% to $4.68
- Closed at $4.68, -1.47% vs the prior close of $4.75. Day range $4.63–$4.77, opened at $4.75.
- Volume was 616.70K shares, 0.7x its 50-day average of 848.56K.
- Price is -21.9% vs its 50-day average ($5.99) and -32.8% vs its 200-day average ($6.97).
- 52-week range $4.48–$13.22; today's close sits at 2% of that range, 64.6% below the 52-week high.
RXST latest news & SEC filings
Every SEC filing by or about RXST in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 16, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Weinberg Eric converted options/RSUs into 35,168 shares at $4.34 (≈$152.63K) on Sep 15, 2026; now holds 235,516
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · SC TO-I/A — SC TO-I/A filing
SC TO-I/A filing
Sep 2, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 25, 2026 · SC TO-I/A — SC TO-I/A filing
SC TO-I/A filing
Aug 19, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $27.24M (prior year $33.64M) (-19.0% vs Jun 30, 2025)
- Net income: -$12.10M (prior year -$11.79M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.29 (prior year -$0.29) ( vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 23, 2026 · S-8 — Registration of shares for employee stock plans (S-8)
Registration of shares for employee stock plans (S-8)
Jul 17, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade RXST
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: Jul 6, 2026, May 6, 2026, Feb 25, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.06% (largest 4.1%).
- Liquidity: about 776.28K shares (≈$3.63M) trade per day on average.
- 52-week position: $4.67 vs a range of $4.40–$13.22 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Ronald M Md Kurtz sold 5,100 shares on Sep 2, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jul 15, 2026.
- Share count: 41.59M shares outstanding (Jul 31, 2026), +1.7% vs a year earlier.
- Listing: Nasdaq · industry: Ophthalmic Goods.
RXST market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 4.59 | 4.71 | 4.55 | 4.67 | 609.20K |
| Oct 14, 2026 | 4.46 | 4.55 | 4.40 | 4.52 | 826.70K |
| Oct 13, 2026 | 4.68 | 4.77 | 4.45 | 4.53 | 694.90K |
| Oct 12, 2026 | 4.85 | 4.98 | 4.55 | 4.66 | 834.60K |
| Oct 9, 2026 | 4.83 | 4.94 | 4.75 | 4.81 | 521.90K |
| Oct 8, 2026 | 4.74 | 4.86 | 4.68 | 4.85 | 938.30K |
| Oct 7, 2026 | 4.61 | 4.95 | 4.61 | 4.80 | 842.20K |
| Oct 6, 2026 | 4.76 | 4.76 | 4.60 | 4.65 | 623.00K |
| Oct 5, 2026 | 4.70 | 4.80 | 4.62 | 4.76 | 483.80K |
| Oct 2, 2026 | 4.75 | 4.77 | 4.63 | 4.68 | 616.70K |
| Oct 1, 2026 | 4.88 | 4.89 | 4.74 | 4.75 | 508.90K |
| Sep 30, 2026 | 4.80 | 4.99 | 4.67 | 4.90 | 705.70K |
| Sep 29, 2026 | 4.67 | 4.78 | 4.62 | 4.77 | 810.90K |
| Sep 28, 2026 | 4.67 | 4.78 | 4.61 | 4.67 | 1.02M |
| Sep 25, 2026 | 4.72 | 4.78 | 4.63 | 4.66 | 1.12M |
| Sep 24, 2026 | 4.85 | 4.91 | 4.67 | 4.73 | 1.22M |
| Sep 23, 2026 | 4.90 | 4.99 | 4.84 | 4.85 | 593.40K |
| Sep 22, 2026 | 5.05 | 5.16 | 4.90 | 4.93 | 848.80K |
| Sep 21, 2026 | 5.21 | 5.34 | 5.05 | 5.14 | 627.70K |
| Sep 18, 2026 | 5.25 | 5.36 | 5.16 | 5.20 | 1.08M |
About RxSight
RxSight (RXST) is listed on the Nasdaq and classified by the SEC under “Ophthalmic Goods”. Its business address is in ALISO VIEJO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1111485.
RXST board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Julie Andrews | Director | Jun 18, 2026 |
| Raymond W Cohen | Director | Jun 18, 2026 |
| Jesse Anderson Corley | Director | Jun 18, 2026 |
| Tamara Fountain | Director | Jun 18, 2026 |
| William J Phd Link | Director | Jun 18, 2026 |
| Shweta Maniar | Director | Jun 18, 2026 |
| Aziz Mottiwala | President and CEO | Jul 24, 2026 |
| Robert J Palmisano | Director | Jun 18, 2026 |
| Bakker Juliet Tammenoms | Director | Jun 18, 2026 |
| Robert Keith Warner | Director | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Scott Gaines | Chief Customer Officer | Mar 3, 2026 |
| Ilya Goldshleger | Chief Operating Officer | Sep 9, 2026 |
| Ronald M Md Kurtz | Chief Medical Officer | Sep 9, 2026 |
| Aziz Mottiwala | President and CEO | Jul 24, 2026 |
| Eric Weinberg | See remarks | Sep 16, 2026 |
| Mark Wilterding | Chief Financial Officer | Sep 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Ronald M Md Kurtz | Sale | 5,100 | $6.96 |
| Sep 2, 2026 | Ilya Goldshleger | Sale | 2,041 | $6.96 |
| Sep 2, 2026 | Eric Weinberg | Sale | 2,041 | $6.96 |
| Sep 2, 2026 | Mark Wilterding | Sale | 7,765 | $6.96 |
RXST financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $134.48M | $-38.94M | -0.95 | $-15.51M |
| Dec 31, 2024 | $139.93M | $-27.45M | -0.71 | $-16.95M |
| Dec 31, 2023 | $89.08M | $-48.61M | -1.41 | $-41.59M |
| Dec 31, 2022 | $49.01M | $-66.76M | -2.41 | $-58.85M |
| Dec 31, 2021 | $22.59M | $-48.69M | -3.57 | $-44.71M |
Latest balance sheet: total assets $352.70M, total liabilities $89.36M, cash $13.35M (as of Jun 30, 2026).
RXST earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $6.29 |
| Jul 6, 2026 | 8-K Item 2.02 (results) | $5.60 |
| May 6, 2026 | 8-K Item 2.02 (results) | $6.78 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $8.81 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $10.09 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $8.34 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $7.79 |
| Jul 8, 2025 | 8-K Item 2.02 (results) | $12.79 |
| May 7, 2025 | 8-K Item 2.02 (results) | $14.90 |
| Apr 3, 2025 | 8-K Item 2.02 (results) | $16.21 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $29.21 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $30.72 |
Related stocks · Ophthalmic Goods
Cooper Companies (COO)Alcon (ALC)Warby Parker (WRBY)National Vision (EYE)Bausch & Lomb (BLCO)Staar Surgical (STAA)Innovative Eyewear (LUCY)Innovative Eyewear (LUCYW)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on RXST
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.